178 related articles for article (PubMed ID: 21780109)
21. Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis.
Torres J; Palmela C; Gomes de Sena P; Santos MPC; Gouveia C; Oliveira MH; Henriques AR; Rodrigues C; Cravo M; Borralho P
GE Port J Gastroenterol; 2018 Jan; 25(1):30-37. PubMed ID: 29457048
[TBL] [Abstract][Full Text] [Related]
22. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
[TBL] [Abstract][Full Text] [Related]
23. High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma.
Giaginis C; Karandrea D; Alexandrou P; Giannopoulou I; Tsourouflis G; Troungos C; Danas E; Keramopoulos A; Patsouris E; Nakopoulou L; Theocharis S
Neoplasma; 2017; 64(4):633-639. PubMed ID: 28485172
[TBL] [Abstract][Full Text] [Related]
24. Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients.
Journe F; Durbecq V; Chaboteaux C; Rouas G; Laurent G; Nonclercq D; Sotiriou C; Body JJ; Larsimont D
Breast Cancer Res Treat; 2009 Jun; 115(3):523-35. PubMed ID: 18563553
[TBL] [Abstract][Full Text] [Related]
25. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
26. Taurochenodeoxycholic acid inhibits intestinal epithelial cell proliferation and induces apoptosis independent of the farnesoid X receptor.
Liu Y; Niu K; Wang R; Liang X; Lin C; Wu X; Zhai Z
Food Funct; 2023 Jun; 14(11):5277-5289. PubMed ID: 37195071
[TBL] [Abstract][Full Text] [Related]
27. Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice.
Fiorucci S; Mencarelli A; Cipriani S; Renga B; Palladino G; Santucci L; Distrutti E
Br J Pharmacol; 2011 Dec; 164(8):1929-38. PubMed ID: 21564085
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
[TBL] [Abstract][Full Text] [Related]
29. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
30. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing.
Mroz MS; Lajczak NK; Goggins BJ; Keely S; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G378-G387. PubMed ID: 29351391
[TBL] [Abstract][Full Text] [Related]
31. [Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy].
Galitskiĭ MV; Khomeriki SG; Nikiforov PA
Eksp Klin Gastroenterol; 2009; (5):28-32. PubMed ID: 20205327
[TBL] [Abstract][Full Text] [Related]
32. Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction.
Wu L; Li W; Wang Z; Yuan Z; Hyder Q
Scand J Gastroenterol; 2013 Apr; 48(4):496-503. PubMed ID: 23410061
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of altered bile acid homeostasis in organic solute transporter-alpha knockout mice.
Lan T; Haywood J; Rao A; Dawson PA
Dig Dis; 2011; 29(1):18-22. PubMed ID: 21691100
[TBL] [Abstract][Full Text] [Related]
34. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Xie C; Jiang C; Shi J; Gao X; Sun D; Sun L; Wang T; Takahashi S; Anitha M; Krausz KW; Patterson AD; Gonzalez FJ
Diabetes; 2017 Mar; 66(3):613-626. PubMed ID: 28223344
[TBL] [Abstract][Full Text] [Related]
35. Bile acids and colon cancer: Solving the puzzle with nuclear receptors.
Degirolamo C; Modica S; Palasciano G; Moschetta A
Trends Mol Med; 2011 Oct; 17(10):564-72. PubMed ID: 21724466
[TBL] [Abstract][Full Text] [Related]
36. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
[TBL] [Abstract][Full Text] [Related]
37. CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.
Wang Z; Pang J; Wang L; Dong Q; Jin D
J Clin Lab Anal; 2022 Nov; 36(11):e24703. PubMed ID: 36129029
[TBL] [Abstract][Full Text] [Related]
38. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
39. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
